» Articles » PMID: 27311404

Contribution of Influenza Viruses to Medically Attended Acute Respiratory Illnesses in Children in High-income Countries: A meta-analysis

Overview
Publisher Wiley
Specialty Microbiology
Date 2016 Jun 18
PMID 27311404
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The burden of disease in children attributable to influenza viruses is difficult to quantify given the similarity of symptoms caused by infection due to influenza and other viruses. This uncertainty impacts clinical decision-making and estimates of burden. We aimed to systematically review the literature to determine the proportion of healthy children presenting for health care with an acute respiratory illness (ARI) who have laboratory-confirmed seasonal influenza (PROSPERO ID#CRD42014013896).

Method: We searched Ovid MEDLINE, EMBASE, Scopus, and references of included articles. We included studies that used polymerase chain reaction methods to test for influenza in healthy children aged ≤5 years who presented for health care in high-income countries with an influenza-like or ARI. A standardized form was used to collect data on positivity and other relevant study elements.

Results: Seventeen studies covering 12 different influenza seasons were included. The proportion of influenza positivity ranged from 11% to 56%. Subgroup analyses were performed by influenza season, continent, healthcare setting, age group, and vaccination status. Higher influenza positivity was reported among children aged 3-5 years compared with children aged ≤2 years, and for unvaccinated children.

Conclusion: The minority of healthy patients aged ≤5 years with medically attended influenza-like or acute respiratory symptoms have laboratory-confirmed influenza virus infection, although this varied by influenza season. Prevention efforts should be targeted accordingly.

Statement: Most influenza-like illnesses are not laboratory-confirmed and have similar clinical presentations. Consequently, the true contribution of influenza to acute respiratory infections in children remains uncertain. Our systematic review estimates that this proportion ranges from 11% to 56%. This finding can help both clinicians and public health professionals target prevention.

Citing Articles

Acute Respiratory Viral Infections Among Adult Patients in Edirne, Turkey.

Bukavaz S, Gungor K, Kole M, Ekuklu G Trop Med Infect Dis. 2025; 10(2).

PMID: 39998062 PMC: 11860308. DOI: 10.3390/tropicalmed10020058.


Prevalence and Surveillance of Influenza Viruses in Hospitalized Patients with Respiratory Infections in and Around Chennai, Southern Part of India.

Sabapathy S, Narasimhachar S, Kuppuswamy A Indian J Microbiol. 2024; 64(4):1551-1557.

PMID: 39678962 PMC: 11645399. DOI: 10.1007/s12088-023-01168-4.


Clinical characteristics and assessment of risk factors in patients with influenza A-induced severe pneumonia after the prevalence of SARS-CoV-2.

Ma Y, Gao Q Open Med (Wars). 2024; 19(1):20240953.

PMID: 38633219 PMC: 11022039. DOI: 10.1515/med-2024-0953.


Protocol for establishing a model for integrated influenza surveillance in Tamil Nadu, India.

Abdulkader R, Potdar V, Mohd G, Chadwick J, Raju M, Devika S Front Public Health. 2023; 11:1236690.

PMID: 37663861 PMC: 10469860. DOI: 10.3389/fpubh.2023.1236690.


[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra 2.0].

Calabro G, Boccalini S, Bechini A, Panatto D, Domnich A, Lai P J Prev Med Hyg. 2023; 63(4 Suppl 1):E1-E140.

PMID: 37034835 PMC: 10079375. DOI: 10.15167/2421-4248/jpmh2022.63.4s1.


References
1.
Henmi M, Copas J . Confidence intervals for random effects meta-analysis and robustness to publication bias. Stat Med. 2010; 29(29):2969-83. DOI: 10.1002/sim.4029. View

2.
Martinez-Baz I, Martinez-Artola V, Reina G, Guevara M, Garcia Cenoz M, Moran J . Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health. 2013; 13:191. PMC: 3599901. DOI: 10.1186/1471-2458-13-191. View

3.
Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C . Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005; 365(9461):773-80. DOI: 10.1016/S0140-6736(05)17984-7. View

4.
Staat M, Griffin M, Donauer S, Edwards K, Szilagyi P, Weinberg G . Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. Vaccine. 2011; 29(48):9005-11. DOI: 10.1016/j.vaccine.2011.09.037. View

5.
Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. DOI: 10.1001/jama.283.15.2008. View